Parker Institute for Cancer Immunotherapy
https://www.parkerici.org/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Parker Institute for Cancer Immunotherapy
Tech Transfer Roundup: Boehringer Teams Up With A*STAR On Targeted Oncology R&D
National Resilience, Parker Institute team to incubate cancer startups. Metropolitan AntiViral Drug Accelerator will focus on eight molecular features of SARS-CoV-2 to create novel oral antivirals.
Company Information
- Industry
- Academic and Research Institutions
- Other Names / Subsidiaries
-
- PICI is an an active research institute that aims to bring different teams together through coordinating scientific strategy and funding collaborative, cross-institutional teams.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice